Table 1.
Study | Location | Initial number | Number of follow-ups | Follow-up time (months) | CHIKV genotype | % Female | Median age (years) | Age category | In-person/ telephone |
---|---|---|---|---|---|---|---|---|---|
(Anwar et al., 2020) | Bangladesh | 48 | 5 | 12 | ECSA/IOL | 52 | 32 | <40 | In-person |
(Bertolotti et al., 2020) | Martinique | 167 | 3 | 12 | Asian | 64 | >50 | ≥40 | Phone |
(Chopra et al., 2012) | India | 509 | 3 | 22.5 | ECSA/IOL | 56 | 25–44 | <40 | In-person |
(de Moraes et al., 2020) | Brazil | 134 | 5 | 12 | ECSA/IOL | 60 | 39 | <40 | In-person |
(Feldstein et al., 2017) | US Virgin Islands | 165 | 2 | 12 | Asian | 65 | 52 | ≥40 | Phone |
(Huits et al., 2018) | Aruba | 171 | 4 | 12 | Asian | 68 | 49 | ≥40 | Phone |
(Kelvin et al., 2011) | Italy | 50 | 2 | 12 | ECSA/IOL | - | - | - | In-person |
(Kularatne et al., 2012) | Sri Lanka | 512 | 4 | 36 | ECSA/IOL | 54 | <33 | <40 | In-person |
(Manimunda et al., 2010) | India | 203 | 2 | 10 | ECSA/IOL | 53 | 35 | <40 | In-person |
(Mohd Zim et al., 2013) | Malaysia | 40 | 2 | 15 | ECSA/IOL | 58 | >40 | ≥40 | Phone |
(Moro et al., 2012) | Italy | 250 | 2 | 12.5 | ECSA/IOL | 54 | >60 | ≥40 | In-person |
(Murillo-Zamora et al., 2017) | Mexico | 136 | 2 | 6 | Asian | 68 | 40–64 | ≥40 | Phone |
(Peters et al., 2018) | Sint Maarten | 56 | 3 | 15 | Asian | 54 | 47 | ≥40 | Phone |
(Sosa-Martínez et al., 2018) | Mexico | 116 | 6 | 18 | Asian | 67 | 51 | ≥40 | In-person |
(Chang et al., 2018; Tritsch et al., 2020) | Colombia | 494 | 2 | 40 | Asian | 80 | 49 | ≥40 | Phone |
(van Genderen et al., 2016) | Suriname | 98 | 2 | 6 | Asian | 68 | 32 | <40 | Phone |
CHIKV, chikungunya virus; ECSA, Central/South African; IOL, Indian Ocean lineage.